(Q43679044)

25 November 2017

title

Impact of abciximab versus eptifibatide on length of hospital stay for PCI patients (English)

1 reference

25 November 2017

M J Lage

1

1 reference

25 November 2017

B L Barber

2

1 reference

25 November 2017

P L McCollam

3

1 reference

25 November 2017

M Bala

4

1 reference

25 November 2017

J Scherer

5

1 reference

25 November 2017

publication date

1 July 2001

1 reference

Catheterization and Cardiovascular Interventions

25 November 2017

published in

1 reference

25 November 2017

volume

53

1 reference

25 November 2017

issue

3

1 reference

25 November 2017

page(s)

296-303

1 reference

An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors

25 November 2017

cites work

1 reference

Glycoprotein IIb/IIIa receptor inhibitors: putting the EPIC, IMPACT II, RESTORE, and EPILOG trials into perspective

21 January 2018

1 reference

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

21 January 2018

1 reference

Sample Selection Bias as a Specification Error

21 January 2018

1 reference

Estimating endogenous treatment effects in retrospective data analysis

21 January 2018

1 reference

Timeliness and quality of care for elderly patients with acute myocardial infarction under health maintenance organization vs fee-for-service insurance.

21 January 2018

1 reference

Gender, racial, and geographic differences in the performance of cardiac diagnostic and therapeutic procedures for hospitalized acute myocardial infarction in four states

21 January 2018

1 reference

Economic issues in glycoprotein IIb/IIIa receptor therapy

21 January 2018

1 reference

Comorbidity as a correlate of length of stay for hospitalized patients with acute chest pain

21 January 2018

1 reference

Effect of institutional volume and academic status on outcomes of coronary interventions: the IMPACT-II experience

21 January 2018

1 reference

Abciximab therapy in percutaneous intervention: economic issues in the United States

21 January 2018

1 reference

Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein grafts

21 January 2018

1 reference

Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (Abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction

21 January 2018

1 reference

Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial

21 January 2018

1 reference

Regional Variation across the United States in the Management of Acute Myocardial Infarction

21 January 2018

1 reference

Sustained Local Delivery of Dexamethasone by a Novel Intravascular Eluting Stent to Prevent Restenosis in the Porcine Coronary Injury Model

21 January 2018

1 reference

Evidence for Prevention of Death and Myocardial Infarction With Platelet Membrane Glycoprotein IIb/IIIa Receptor Blockade by Abciximab (c7E3 Fab) Among Patients With Unstable Angina Undergoing Percutaneous Coronary Revascularization fn1fn1This study

21 January 2018

1 reference

An overview of the results of the EPIC trial

21 January 2018

1 reference

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade.

21 January 2018

1 reference

The relationship between hospital length of stay and rate of death in heart failure

21 January 2018

1 reference

Early readmission of elderly patients with congestive heart failure

21 January 2018

1 reference

Health care costs and outcomes: how should we evaluate real world data?

21 January 2018

1 reference

Length of hospital stay after acute myocardial infarction in the Myocardial Infarction Triage and Intervention (MITI) Project registry

21 January 2018

1 reference

The association of hospital volumes of percutaneous transluminal coronary angioplasty with adverse outcomes, length of stay, and charges in California.

21 January 2018

1 reference

The effect of complications on length of stay

21 January 2018

1 reference

Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty. EPIC Investigators

21 January 2018

1 reference

Rapid intravenous infusion of d-1 sotalol: time to onset of effects on ventricular refractoriness, and safety

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/CCD.1170

1 reference

25 November 2017

1 reference